International Patent: IMPROVED RAPAMYCIN ACTIVATED SYNTHETIC RECEPTOR TRANSGENE CONSTRUCTS

GENEVA, July 6 -- UMOJA BIOPHARMA, INC. filed a patent application (US2025/061054) for “IMPROVED RAPAMYCIN ACTIVATED SYNTHETIC RECEPTOR TRANSGENE CONSTRUCTS”. With publication no. WO/2026/143070, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....